Metrion Biosciences Limited, a specialist ion channel contract research and drug discovery company, has received notification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) that it is now a member of the UK GLP (Good Laboratory Practice) compliance monitoring program and is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community. GLP hERG screening is a vital step in the transition from preclinical research to P...